Logo image of ATPC

AGAPE ATP CORP (ATPC) Stock Fundamental Analysis

NASDAQ:ATPC - Nasdaq - US0083892077 - Common Stock - Currency: USD

1.3116  -0.06 (-4.26%)

Fundamental Rating

2

Taking everything into account, ATPC scores 2 out of 10 in our fundamental rating. ATPC was compared to 103 industry peers in the Health Care Providers & Services industry. The financial health of ATPC is average, but there are quite some concerns on its profitability. ATPC has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ATPC had negative earnings in the past year.
ATPC had a negative operating cash flow in the past year.
ATPC had negative earnings in 4 of the past 5 years.
ATPC had a negative operating cash flow in each of the past 5 years.
ATPC Yearly Net Income VS EBIT VS OCF VS FCFATPC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1M -2M

1.2 Ratios

With a Return On Assets value of -9.77%, ATPC is not doing good in the industry: 76.70% of the companies in the same industry are doing better.
ATPC has a worse Return On Equity (-10.23%) than 60.19% of its industry peers.
Industry RankSector Rank
ROA -9.77%
ROE -10.23%
ROIC N/A
ROA(3y)-57.8%
ROA(5y)-44.39%
ROE(3y)-95.22%
ROE(5y)-71.18%
ROIC(3y)N/A
ROIC(5y)N/A
ATPC Yearly ROA, ROE, ROICATPC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 -100

1.3 Margins

The Gross Margin of ATPC (55.07%) is better than 77.67% of its industry peers.
ATPC's Gross Margin has improved in the last couple of years.
ATPC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 55.07%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.67%
GM growth 5Y51.9%
ATPC Yearly Profit, Operating, Gross MarginsATPC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

More info and screens

6

2. Health

2.1 Basic Checks

ATPC does not have a ROIC to compare to the WACC, probably because it is not profitable.
ATPC has more shares outstanding than it did 1 year ago.
The number of shares outstanding for ATPC has been reduced compared to 5 years ago.
Compared to 1 year ago, ATPC has a worse debt to assets ratio.
ATPC Yearly Shares OutstandingATPC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
ATPC Yearly Total Debt VS Total AssetsATPC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

2.2 Solvency

ATPC has an Altman-Z score of 34.95. This indicates that ATPC is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 34.95, ATPC belongs to the best of the industry, outperforming 98.06% of the companies in the same industry.
ATPC has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of ATPC (0.00) is better than 83.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 34.95
ROIC/WACCN/A
WACC9.03%
ATPC Yearly LT Debt VS Equity VS FCFATPC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M

2.3 Liquidity

A Current Ratio of 24.67 indicates that ATPC has no problem at all paying its short term obligations.
ATPC has a Current ratio of 24.67. This is amongst the best in the industry. ATPC outperforms 100.00% of its industry peers.
ATPC has a Quick Ratio of 24.63. This indicates that ATPC is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of ATPC (24.63) is better than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 24.67
Quick Ratio 24.63
ATPC Yearly Current Assets VS Current LiabilitesATPC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for ATPC have decreased strongly by -19.14% in the last year.
Looking at the last year, ATPC shows a decrease in Revenue. The Revenue has decreased by -5.59% in the last year.
The Revenue has been decreasing by -3.12% on average over the past years.
EPS 1Y (TTM)-19.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60.57%
Revenue 1Y (TTM)-5.59%
Revenue growth 3Y9.05%
Revenue growth 5Y-3.12%
Sales Q2Q%-9.29%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ATPC Yearly Revenue VS EstimatesATPC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ATPC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ATPC Price Earnings VS Forward Price EarningsATPC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ATPC Per share dataATPC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ATPC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AGAPE ATP CORP

NASDAQ:ATPC (7/25/2025, 8:00:01 PM)

1.3116

-0.06 (-4.26%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)05-15 2025-05-15
Earnings (Next)08-12 2025-08-12
Inst Owners0.01%
Inst Owner Change0%
Ins Owners1.97%
Ins Owner ChangeN/A
Market Cap65.59M
AnalystsN/A
Price TargetN/A
Short Float %0.31%
Short Ratio0.67
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 50.73
P/FCF N/A
P/OCF N/A
P/B 2.73
P/tB 2.73
EV/EBITDA N/A
EPS(TTM)-0.52
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS0.03
BVpS0.48
TBVpS0.48
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.77%
ROE -10.23%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 55.07%
FCFM N/A
ROA(3y)-57.8%
ROA(5y)-44.39%
ROE(3y)-95.22%
ROE(5y)-71.18%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.67%
GM growth 5Y51.9%
F-Score3
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 88.99%
Cap/Sales 3.94%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 24.67
Quick Ratio 24.63
Altman-Z 34.95
F-Score3
WACC9.03%
ROIC/WACCN/A
Cap/Depr(3y)66.43%
Cap/Depr(5y)39.86%
Cap/Sales(3y)3.02%
Cap/Sales(5y)1.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-19.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60.57%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.59%
Revenue growth 3Y9.05%
Revenue growth 5Y-3.12%
Sales Q2Q%-9.29%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-6.17%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-198.74%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-215.76%
OCF growth 3YN/A
OCF growth 5YN/A